Ticker Symbol: NKTR
Nektar Therapeutics
$13.29 - 20-12-2024 4 p.m. ET
Exchange: NASDAQ
Country:
US
Currency:
USD
Asset
Type: Common Stock
CIK:0000906709
Company Profile
Nektar Therapeutics is a biopharmaceutical company with a robust, wholly owned R&D pipeline of investigational medicines in oncology, immunology, and virology as well as a portfolio of approved partnered medicines. Nektar is headquartered in San Francisco, California, with additional operations in Huntsville, Alabama and Hyderabad, India.
Sector: Manufacturing
Industry: Pharmaceutical Preparation Manufacturing
Standard Industrial Classification Code (SIC code): 2834
Address: 455 Mission Bay Blvd S
Website: www.nektar.com
CEO: Howard Robin
Tags:
- Health Technology
- Biotechnology
- Pharmaceuticals: Major
- Manufacturing
- Pharmaceutical Preparation Manufacturing
Pricing
Last Updated: October 3, 2023 03:00 PM EST
Previous Close: $0.54
Change:
-$0.02
(
-4.16%)
Days Range: $0.54 - $0.57
Beta: 2.04
52wk. High: $4.37
52wk. Low: $0.49
Ytd. Change -78.94%
50 Day Moving Average: $0.59
200 Day Moving Average: $0.66
Shares Outstanding: 190118673
Valuation
Market Cap: 10.4B
PE Ratio: -0.34
EPS (TTM): -1.63
Dividends
Dividend Per Share (TTM): -
Dividend Yield (TTM): 0.00%
Ex-Dividend Date: N/A